Conductor, the only end-to-end, enterprise AEO platform, today announced strong momentum through Q3, driven by accelerating enterprise adoption as AI search became a core performance channel. Q3 ...
Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has ...